Your browser doesn't support javascript.
loading
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials.
Goldman, Jennifer G; Forsberg, Leah K; Boeve, Bradley F; Armstrong, Melissa J; Irwin, David J; Ferman, Tanis J; Galasko, Doug; Galvin, James E; Kaufer, Daniel; Leverenz, James; Lippa, Carol F; Marder, Karen; Abler, Victor; Biglan, Kevin; Irizarry, Michael; Keller, Bill; Munsie, Leanne; Nakagawa, Masaki; Taylor, Angela; Graham, Todd.
Afiliação
  • Goldman JG; Parkinson's Disease and Movement Disorders Program, Shirley Ryan AbilityLab and Departments of Physical Medicine and Rehabilitation and Neurology, Northwestern University Feinberg School of Medicine, 355 E. Erie Street, Chicago, IL, 60611, USA. jgoldman02@sralab.org.
  • Forsberg LK; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Boeve BF; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Armstrong MJ; Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA.
  • Irwin DJ; Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Ferman TJ; Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA.
  • Galasko D; Department of Neurosciences, UC San Diego, San Diego, CA, USA.
  • Galvin JE; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Kaufer D; Department of Neurology, University of North Carolina, Chapel Hill, NC, USA.
  • Leverenz J; Lou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Lippa CF; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Marder K; Department of Neurology, Taub Institute, Sergievsky Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Abler V; Acadia Pharmaceuticals, San Diego, CA, USA.
  • Biglan K; Neuroscience Research, Eli Lilly and Company, Indianapolis, IN, USA.
  • Irizarry M; Neurology Business Group, Eisai, Inc., Woodcliff Lake, NJ, USA.
  • Keller B; Acadia Pharmaceuticals, San Diego, CA, USA.
  • Munsie L; Neuroscience Research, Eli Lilly and Company, Indianapolis, IN, USA.
  • Nakagawa M; Neurology Business Group, Eisai Co., Ltd., Tokyo, Japan.
  • Taylor A; Lewy Body Dementia Association, S.W., Lilburn, GA, USA.
  • Graham T; Lewy Body Dementia Association, S.W., Lilburn, GA, USA.
Alzheimers Res Ther ; 12(1): 137, 2020 10 29.
Article em En | MEDLINE | ID: mdl-33121510

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença por Corpos de Lewy / Doença de Alzheimer Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Alzheimers Res Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença por Corpos de Lewy / Doença de Alzheimer Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Alzheimers Res Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos